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Breast carcinoma is one of the most common causes of death among 
women, and metastasis is the leading cause of mortality in these patients. 
Despite all efforts, the factors that support metastasis are not completely 
elucidated. Most of women with advanced breast cancer have regional 
nodal metastases and more than 30% develop distant metastases. Data 
about lymphangiogenesis in the tumor stroma are scattered. 
To study and synthesize bibliographic data in order to 
determine the molecular factors involved in the process of 
lymphangiogenesis of breast carcinoma.
Figure 1. Growth factor and cytokine 
signaling pathways in lymphangiogenesis.
Lymphangiogenesis, breast cancer.
VEGF-C, VEGFR-3, D2-40 and Prox-1 are lymphangiogenic markers 
expressed in the stroma of breast carcinomas. These data provide 
evidence for tumor lymphangiogenesis and emphasize their diagnostic 
importance. 
The study is based on the 
analysis of bibliographic 
sources published in scientific 
databases in the country and 
abroad.
Figure 2. Immunohistochemical 
double staining for D2-40 and Ki-67 
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Lymphovascular invasion was detected in hematoxylin-eosin stained 
sections in 13,8-16% of cases of breast cancer and 28,5% by 
immunohistochemistry with markers for Podoplanin. 
Figure 3.
(Wei Zheng,Aleksanteri Aspelund,Kari Alitalo Lymphangiogenic 
factors, mechanisms, and applications,2014,878–887)
